Harpswell Capital Advisors’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$150K Buy
+12,822
New +$102K 0.1% 42

Other funds holding RCEL

Harpswell Capital Advisors's RCEL Position: Q3 2026 in Review

Harpswell Capital Advisors opened a new position in Avita Medical (RCEL) in Q3 2026: 12,822 shares worth $150K. The stake represents 0.1% of the portfolio and ranks #42 among its holdings.

2 funds tracked by Wall St. Rank hold RCEL as of Q3 2026.

  • Harpswell Capital Advisors held 12,822 shares of Avita Medical worth $150K as of Q3 2026.
  • Avita Medical was a new Harpswell Capital Advisors position in Q3 2026.
  • Avita Medical made up 0.1% of Harpswell Capital Advisors's portfolio in Q3 2026, its #42 holding.
  • 2 funds tracked by Wall St. Rank held Avita Medical as of Q3 2026.

Based on Harpswell Capital Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.